In this video interview, John Browning, MD, comments on the recent pediatric indication approved for ruxolitinib to treat atopic dermatitis.
John Browning, MD
Advertisement
John Browning, MD, Chief of Dermatology at Children’s Hospital of San Antonio and Organon Health Partner.
Articles by John Browning, MD
John Browning, MD, highlights the importance of fragrance-free, steroid-free creams in managing atopic dermatitis safely and effectively in children.
Pediatric dermatologist John Browning, MD, offers practical sun safety tips and guidance for selecting sunscreens, emphasizing the importance of choosing formulations that work for sensitive skin.
John Browning, MD, highlights why pediatricians should feel comfortable prescribing recent nonsteroidal medications and what questions to ask patients in the office.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Julie Khlevner, MD, discusses the impact of FDA-approved LINZESS for functional constipation
2
FDA approves ensitrelvir for post-exposure prevention of COVID-19 in adolescents and adults
3
Recognizing the skin findings that distinguish pediatric hidradenitis suppurativa
4
Colleen Cotton, MD, on the importance of early recognition in hidradenitis suppurativa
5